Your browser doesn't support javascript.
loading
Population-based head-to-head comparison of the clinical characteristics and epidemiology of AQP4 antibody-positive NMOSD between two European countries.
Viktoria, Papp; Trones, Kim D P; Magyari, Melinda; Koch-Henriksen, Nils; Iljicsov, Anna; Rajda, Cecilia; Nielsen, Helle H; Lovas, Gabor; Rozsa, Csilla; Kristiansen, Bjørn H; Stenager, Egon; Frederiksen, Jette L; Komoly, Samuel; Sellebjerg, Finn; Petersen, Thor; Illes, Zsolt.
Affiliation
  • Viktoria P; Department of Neurology, Odense University Hospital, Odense, Denmark. Electronic address: papp.vittoria@gmail.com.
  • Trones KDP; University of Southern Denmark, Odense, Denmark.
  • Magyari M; The Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Glostrup, Denmark; The Danish Multiple Sclerosis Registry, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.
  • Koch-Henriksen N; The Danish Multiple Sclerosis Registry, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
  • Iljicsov A; Department of Neurology, Semmelweis University, Budapest, Hungary.
  • Rajda C; Department of Neurology, University of Szeged, Szeged, Hungary.
  • Nielsen HH; Department of Neurology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark; Institute of Molecular Biology, University of Southern Denmark, Odense, Denmark.
  • Lovas G; Department of Neurology, Jahn Ferenc Hospital, Budapest, Hungary.
  • Rozsa C; Department of Neurology, Jahn Ferenc Hospital, Budapest, Hungary.
  • Kristiansen BH; University of Southern Denmark, Odense, Denmark.
  • Stenager E; MS-clinic of Southern Jutland (Sønderborg, Esbjerg, Kolding), Department of Neurology, Hospital of Southern Jutland, Sønderborg, Denmark; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Frederiksen JL; Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark.
  • Komoly S; Department of Neurology, University of Pécs, Pécs, Hungary.
  • Sellebjerg F; The Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Glostrup, Denmark; The Danish Multiple Sclerosis Registry, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.
  • Petersen T; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
  • Illes Z; Department of Neurology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Mult Scler Relat Disord ; 51: 102879, 2021 Jun.
Article in En | MEDLINE | ID: mdl-33714126
ABSTRACT

BACKGROUND:

Population-based clinical studies in neuromyelitis optica spectrum disorder (NMOSD) and epidemiological and clinical comparisons of White ethnicities are missing. In a large population-based international cohort, we extensively characterized aquaporin-4 antibody seropositive (AQP4-Ab+) NMOSD, and also compared the clinical, radiological and epidemiological features between two European populations residing in different areas.

METHODS:

Between self-reported Danish and Hungarian ethnicities, we compared the population-based clinical features, disability outcomes, and death of 134 AQP4-Ab+ NMOSD cases fulfilling the 2015 International Panel for NMO Diagnosis (IPND) criteria. For precise comparison of epidemiology, we conducted a population-based head-to-head comparative study of the age-standardized prevalence (January 1, 2014) and incidence (2007-2013) of AQP4-Ab+ NMO/NMOSD among adults (≥16 years) in Denmark (4.6 million) and Hungary (6.4 million) by applying 2015 IPND (NMOSD) criteria and 2006 Wingerchuk (NMO).

RESULTS:

Danes were more likely to present with transverse myelitis and were more affected by spinal cord damage on long-term disability. Hungarians presented most often with optic neuritis, although visual outcome was similar in the groups. No differences were observed in sex, disease course, relapse rate, autoimmune comorbidity, mortality, brain MRI, and treatment strategies. The age-standardized prevalence estimates of AQP4-Ab+ NMOSD (2015 IPND criteria) in Denmark vs. Hungary were 0.66 vs. 1.43 (/100,000) while incidence rates were 0.04 vs. 0.11 (/100,000 person-years); similar differences were found based on the 2006 NMO criteria.

CONCLUSIONS:

This head-to-head comparative study indicates different disease characteristics and epidemiology among White populations in Europe, and substantiates the need for population-based genetic and environmental studies in NMOSD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuromyelitis Optica Type of study: Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Humans Country/Region as subject: Europa Language: En Journal: Mult Scler Relat Disord Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuromyelitis Optica Type of study: Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Humans Country/Region as subject: Europa Language: En Journal: Mult Scler Relat Disord Year: 2021 Document type: Article